These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Ras activation in human breast cancer. von Lintig FC; Dreilinger AD; Varki NM; Wallace AM; Casteel DE; Boss GR Breast Cancer Res Treat; 2000 Jul; 62(1):51-62. PubMed ID: 10989985 [TBL] [Abstract][Full Text] [Related]
46. Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Walsh MD; Luckie SM; Cummings MC; Antalis TM; McGuckin MA Breast Cancer Res Treat; 1999 Dec; 58(3):255-66. PubMed ID: 10718487 [TBL] [Abstract][Full Text] [Related]
47. MUC1 triggers lineage plasticity of Her2 positive mammary tumors. Pang Z; Dong X; Deng H; Wang C; Liao X; Liao C; Liao Y; Tian W; Cheng J; Chen G; Yi H; Huang L Oncogene; 2022 May; 41(22):3064-3078. PubMed ID: 35461328 [TBL] [Abstract][Full Text] [Related]
48. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Kufe DW Oncogene; 2013 Feb; 32(9):1073-81. PubMed ID: 22580612 [TBL] [Abstract][Full Text] [Related]
49. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Zuo T; Wang L; Morrison C; Chang X; Zhang H; Li W; Liu Y; Wang Y; Liu X; Chan MW; Liu JQ; Love R; Liu CG; Godfrey V; Shen R; Huang TH; Yang T; Park BK; Wang CY; Zheng P; Liu Y Cell; 2007 Jun; 129(7):1275-86. PubMed ID: 17570480 [TBL] [Abstract][Full Text] [Related]
50. Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma. Hollywood DP; Hurst HC Br J Cancer; 1995 Apr; 71(4):753-7. PubMed ID: 7710940 [TBL] [Abstract][Full Text] [Related]
51. Regulation of DNA methylation by the Ras signaling pathway. MacLeod AR; Rouleau J; Szyf M J Biol Chem; 1995 May; 270(19):11327-37. PubMed ID: 7744770 [TBL] [Abstract][Full Text] [Related]
52. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. Yin L; Li Y; Ren J; Kuwahara H; Kufe D J Biol Chem; 2003 Sep; 278(37):35458-64. PubMed ID: 12826677 [TBL] [Abstract][Full Text] [Related]
53. ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer. Hasegawa T; Adachi R; Iwakata H; Takeno T; Sato K; Sakamaki T FEBS Open Bio; 2017 Aug; 7(8):1154-1165. PubMed ID: 28781955 [TBL] [Abstract][Full Text] [Related]
54. Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Benz CC; Fedele V; Xu F; Ylstra B; Ginzinger D; Yu M; Moore D; Hall RK; Wolff DJ; Disis ML; Eppenberger-Castori S; Eppenberger U; Schittulli F; Tommasi S; Paradiso A; Scott GK; Albertson DG Genes Chromosomes Cancer; 2006 Nov; 45(11):983-94. PubMed ID: 16883574 [TBL] [Abstract][Full Text] [Related]
55. Increased expression after X-irradiation of MUC1 in cultured human colon carcinoma HT-29 cells. Kang Y; Hirano K; Suzuki N; Enomoto A; Morita A; Irimura T; Sakai K Jpn J Cancer Res; 2000 Mar; 91(3):324-30. PubMed ID: 10760692 [TBL] [Abstract][Full Text] [Related]
56. MUC1 mucin interacts with calcium-modulating cyclophilin ligand. Guang W; Kim KC; Lillehoj EP Int J Biochem Cell Biol; 2009 Jun; 41(6):1354-60. PubMed ID: 19135167 [TBL] [Abstract][Full Text] [Related]
57. Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin. Meerzaman D; Xing PX; Kim KC Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L625-9. PubMed ID: 10710536 [TBL] [Abstract][Full Text] [Related]
58. Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth. Kakhlon O; Gruenbaum Y; Cabantchik ZI Biochem Soc Trans; 2002 Aug; 30(4):777-80. PubMed ID: 12196194 [TBL] [Abstract][Full Text] [Related]